Every serious supplement manufacturer tests its products. The question that separates marketing from quality assurance is who does the testing, against what standard, and with what independence. This is where third-party laboratories — global networks such as Eurofins, SGS, Intertek and national accredited labs — occupy a categorically different position from a manufacturer’s own bench.
- The conflict-of-interest problem
- What batch testing actually measures
- Batch-level versus product-level claims
- How ISO/IEC 17025 accreditation actually works
- Reading a certificate of analysis line by line
- Skip-lot testing versus every-batch testing
- Why some brands skip it: the honest economics
- The clinical bottom line
- Primary sources
The conflict-of-interest problem
In-house quality control faces a structural conflict: the laboratory reports to the same management whose batch is at stake. Most manufacturers handle this honestly; the system nonetheless depends on internal culture rather than external checks. An independent laboratory has the opposite incentive structure — its entire business value is its credibility, formalised through ISO/IEC 17025 accreditation, the international standard for testing-laboratory competence, under which national accreditation bodies audit the lab’s methods, equipment calibration, staff qualification and result traceability.
What batch testing actually measures
A meaningful third-party certificate of analysis (CoA) for a supplement batch typically covers: identity (is the declared ingredient actually present — increasingly verified by spectroscopic or DNA methods), potency (does the assayed amount match the label within tolerance), heavy metals (lead, arsenic, cadmium, mercury against limits such as USP or EU regulation 2023/915), microbiology (total counts, E. coli, Salmonella), and where relevant oxidation markers — peroxide and anisidine values for omega-3 oils, for example, where freshness is the core quality variable.
Batch-level versus product-level claims
The word batch carries the weight. A one-time product test proves a formulation could be made correctly once; batch testing proves the batch you are actually holding was made correctly. Manufacturers who publish per-batch CoAs — ideally retrievable by the lot number printed on the package — convert quality from a claim into a checkable fact. This is the model behind lot-verification systems now appearing across the industry.
How ISO/IEC 17025 accreditation actually works
Accreditation is not a certificate a lab buys once. A national accreditation body (members of the ILAC mutual-recognition arrangement) assesses the laboratory’s entire quality system: method validation files, measurement-uncertainty budgets, equipment calibration chains traceable to national standards, analyst competence records, and — critically — proficiency testing, in which the lab periodically analyses blind samples with known values and must land within tolerance against peer laboratories worldwide. Assessments repeat on a defined cycle with surveillance visits between; scope is granted test-by-test, so a lab may be accredited for heavy metals by ICP-MS but not for vitamin assays. The practical check for a consumer or brand: the CoA should carry the accreditation body’s mark and a scope-relevant method reference.
Reading a certificate of analysis line by line
A CoA is a table of five columns worth understanding. Parameter (what was tested), method (the compendial or validated procedure — its absence is the first red flag), specification (the pass/fail limit), result, and units. Two literacy points prevent most misreadings: “
Skip-lot testing versus every-batch testing
Regulations typically require manufacturers to establish specifications and test “a subset of finished batches” under a statistically justified plan — skip-lot testing. That is defensible engineering for a stable, validated process; it is also why “we test our products” can be true while the specific bottle in your hand was in an untested lot. Brands that commit to every-batch third-party testing with lot-retrievable certificates are exceeding the regulatory floor, and the difference is exactly the gap between statistical assurance about a process and direct evidence about your unit.
Why some brands skip it: the honest economics
A full third-party panel — identity, assay, four heavy metals, micro, plus oxidation markers for oils — costs from a few hundred to over a thousand dollars per batch depending on matrix and methods. On a small production run, that is a visible slice of margin; on a mass-market run it is cents per bottle. The economics mean testing depth correlates less with price point than with brand philosophy — and it is why the presence of accessible, batch-specific, accredited CoAs is such an efficient screening question: it is a cost only quality-committed operations choose to carry.
The clinical bottom line
Self-testing is necessary; independent testing is credible. Look for three markers: an ISO 17025-accredited laboratory, batch-specific (not generic) certificates, and public retrievability by lot number. Together they represent the strongest quality signal a consumer can verify without a laboratory of their own.
Primary sources
- ISO/IEC 17025:2017 — General requirements for the competence of testing and calibration laboratories
- USP: Dietary supplement quality standards, incl. elemental impurities
- Commission Regulation (EU) 2023/915 on maximum levels for certain contaminants in food
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
